Lohit Jagwani
Healthcare
Glaxo completes $1B open offer to raise stake in Indian pharma arm to 75%
British pharmaceutical giant GlaxoSmithKline Plc (GSK) has completed its voluntary open offer for the Indian pharma arm, spending around Rs ......
Healthcare
Apollo Hospitals scraps proposed fundraising through business trust in Singapore
Apollo Hospitals Enterprise Ltd, country’s largest healthcare services provider by market capitalisation, has decided to scrap a proposal to list ......
Healthcare
RG Stone in talks with investors to raise $16M
RG Scientific Enterprise Pvt Ltd, which operates a chain of urology and laparoscopy hospitals in the country, is in talks ......
Healthcare
AstraZeneca's Indian arm asks for more information from parent on delisting offer
AstraZeneca Pharma India Ltd, the domestic arm of the British-Swedish drug maker, said its board of directors has asked for ......
Healthcare
IFC leading $10M Series B investment in NephroPlus
International Finance Corp, the private sector lending arm of World Bank group, is leading a Series B investment of $10 ......
Healthcare
Apollo foraying into single specialty with oncology, cardiology hospitals
Apollo Hospitals Enterprise Ltd, India’s largest healthcare services company by market capitalisation, is foraying into the single-specialty segment with focus ......
General
TVM Capital MENA plans to raise around $150M fund for emerging markets
Healthcare focused private equity firm TVM Capital MENA is looking to raise a new emerging markets fund with a target ......
TMT
Online healthcare marketplace DocTree raises funding from S4 Holdings
Bangalore-based Doctree Health Infoservices Pvt Ltd, which provides web-based services to patients looking for treatments and price quotes from various ......
General
TVM Capital's healthcare fund plans to invest over $100M in India in 3-5 years
TVM Capital MENA, a healthcare focused fund which invests in emerging markets, will invest over $100 million in India in ......
Healthcare
Ranbaxy suspends shipment of drugs from two plants
Indian drug major Ranbaxy Laboratories Ltd has announced that it has temporarily suspended shipment from its two active pharmaceutical ingredients ......